Given both antibody titers and T cell responses are associated with protective COVID‐19 outcomes [50–52], our results highlight the centrality of CD4+ T cell in the vaccine‐induced protective immunity against SARS‐CoV‐2. This evidence concerns the gene CD4 and COVID-19.